Preservation of the donor pancreas for whole pancreas and islet transplantation

Clinical Transplantation

Volumn 24, Issue 1, 2010, Pages 1-19

  Ridgway, Dan ^a   Manas, Derek ^b   Shaw, James ^b   White, Steve ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Islet cell transplantation; Machine perfusion; Pancreas preservation; Pancreas transplantation; Perfusive preservation; Two layered method

Indexed keywords

CATECHOLAMINE DERIVATIVE; GLYCERYL TRINITRATE; INSULIN; OXYGEN; PHENTOLAMINE; PROSTACYCLIN; PROSTAGLANDIN E2; STEROID; VASOPRESSIN;

ALLOGRAFT; AUTOTRANSPLANTATION; CADAVER DONOR; CELL ISOLATION; CRYOPRESERVATION; DIABETES MELLITUS; DONOR SELECTION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPOXIA; IMMUNE RESPONSE; IMMUNOGENICITY; ISCHEMIA; KIDNEY PANCREAS TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; OXYGENATION; PANCREAS DISEASE; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPERFUSION; REVIEW; SURGICAL TECHNIQUE; SURGICAL TECHNOLOGY; SURVIVAL RATE;

HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; ORGAN PRESERVATION; PANCREAS TRANSPLANTATION; TISSUE AND ORGAN HARVESTING; WARM ISCHEMIA;

EID: 74949130468     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01151.x     Document Type: Review

References (226)

1. Sureshkumar KK, Patel BM, Markatos A, Nghiem DD, Marcus RJ. Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease. Clin Transplant 2006, 20:19.
2. Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol 2003, 14:208.
3. Knoll GA, Nichol G. Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: a decision analysis of treatment options. J Am Soc Nephrol 2003, 14:500.
4. Registry CIT. Annual Report 2006 2006, Bethesda, MD, National Institute of Diabetes & Digestive & Kidney Diseases
5. Shapiro AM, Ricordi C, Hering BJ. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318.
6. Sayegh MH, Carpenter CB. Transplantation 50 years later - progress, challenges, and promises. N Engl J Med 2004, 351:2761.
7. Registry CIT. Annual Report 2007 2007, Bethesda, MD, National Institute of Diabetes & Digestive & Kidney Diseases
8. Gruessner RW, Sutherland DE, Kandaswamy R, Gruessner AC. Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation 2008, 85:42.
9. Hering BJ. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation 2005, 79:1296.
10. Ridgway DM, White SA, Kimber RM, Nicholson ML. Current practices of donor pancreas allocation in the UK: future implications for pancreas and islet transplantation. Transpl Int 2005, 18:828.
11. Barber K, Falvey S, Hamilton C, Collett D, Rudge C. Potential for organ donation in the United Kingdom: audit of intensive care records. BMJ 2006, 332:1124.
12. Stegall MD, Dean PG, Sung R. The rationale for the new deceased donor pancreas allocation schema. Transplantation 2007, 83:1156.
13. Fiedor P, Goodman ER, Sung RS, Czerwinski J, Rowinski W, Hardy MA. The effect of clinical and biochemical donor parameters on pancreatic islet isolation yield from cadaveric organ donors. Ann Transplant 1996, 1:59.
14. Witkowski P, Liu Z, Cernea S. Validation of the scoring system for standardization of the pancreatic donor for islet isolation as used in a new islet isolation center. Transplant Proc 2006, 38:3039.
15. O'Gorman D, Kin T, Murdoch T. The standardization of pancreatic donors for islet isolation. Transplant Proc 2005, 37:1309.
16. Gruessner A, Gruessner R, Moudry-Munns K, Dunn D, Najarian JS, Sutherland DE. Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. Transplant Proc 1993, 25(1 Pt 2):1303.
17. Stratta RJ. Donor age, organ import, and cold ischemia: effect on early outcomes after simultaneous kidney-pancreas transplantation. Transplant Proc 1997, 29:3291.
18. Salvalaggio PR, Schnitzler MA, Abbott KC. Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant 2007, 7:1561.
19. Ishibashi M, Ito T, Sugitani A. Present status of pancreas transplantation in Japan - donation predominantly from marginal donors and modified surgical technique: report of Japan pancreas transplantation registry. Transplant Proc 2008, 40:486.
20. Nghiem DD, Corry RJ. Effects of donor size on long-term function of simultaneous renal and pancreatic transplants from pediatric donors. Transplant Proc 1989, 21(1 Pt 3):2841.
21. Schulz T, Schenker P, Flecken M, Kapischke M. Donors with a maximum body weight of 50 kg for simultaneous pancreas-kidney transplantation. Transplant Proc 2005, 37:1268.
22. Brandhorst D, Hering BJ, Brandhorst H, Federlin K, Bretzel RG. Influence of donor data and organ procurement on human islet isolation. Transplant Proc 1994, 26:592.
23. Lakey JR, Warnock GL, Rajotte RV. Factors in cadaveric donors that affect recovery of human islets of Langerhans. Transplant Proc 1995, 27:3265.
24. Brandhorst H, Brandhorst D, Hering BJ, Federlin K, Bretzel RG. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995, 103(Suppl 2):23.
25. Ponte GM, Pileggi A, Messinger S. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant 2007, 16:595.
26. Balamurugan AN, Chang Y, Bertera S. Suitability of human juvenile pancreatic islets for clinical use. Diabetologia 2006, 49:1845.
27. Matsumoto I, Sawada T, Nakano M. Improvement in islet yield from obese donors for human islet transplants. Transplantation 2004, 78:880.
28. Nano R, Clissi B, Melzi R. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia 2005, 48:906.
29. Krieger NR, Odorico JS, Heisey DM. Underutilization of pancreas donors. Transplantation 2003, 75:1271.
30. Porrett PM, Yeh H, Frank A. Availability of suitable islet donors in the United States. Transplantation 2007, 84:280.
31. Flormann SS, Starzl TE, Miller CM, Wilmore DW, Cheung LY, Harken AH. Organ Procurement. ACS Surgery: Principles and Practice 2008, Online subscription accessed June 2008. In, eds, New York, WebMD Inc
32. D'Alessandro AM, Odorico JS, Knechtle SJ. Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). Cell Transplant 2000, 9:889.
33. Sollinger HW, Ploeg RJ, Eckhoff DE. Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery 1993, 114:736. discussion 743-4
34. Markmann JF, Deng S, Desai NM. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 2003, 75:1423.
35. Goto T, Tanioka Y, Sakai T. Successful islet transplantation from a single pancreas harvested from a young, low-BMI, non-heart-beating cadaver. Transplant Proc 2005, 37:3430.
36. Matsumoto S, Noguchi H, Hatanaka N. Estimation of donor usability for islet isolation with the modified Ricordi method. Transplant Proc 2008, 40:362.
37. Zhao M, Muiesan P, Amiel SA. Human islets derived from donors after cardiac death are fully biofunctional. Am J Transplant 2007, 7:2318.
38. Noguchi H, Iwanaga Y, Okitsu T, Nagata H, Yonekawa Y, Matsumoto S. Evaluation of islet transplantation from non-heart beating donors. Am J Transplant 2006, 6:2476.
39. Pratschke J, Wilhelm MJ, Kusaka M. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999, 67:343.
40. Ogliari AC, Caldara R, Socci C. High levels of donor CCL2/MCP-1 predict graft-related complications and poor graft survival after kidney-pancreas transplantation. Am J Transplant 2008, 8:1303.
41. Contreras JL, Eckstein C, Smyth CA. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003, 52:2935.
42. Jung HS, Choi SH, Kim SJ. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant 2007, 21:738.
43. Matsumoto S, Tanaka K, Strong DM, Reems JA. Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation 2004, 78:839.
44. Matsumoto S, Okitsu T, Iwanaga Y. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005, 365:1642.
45. Matsumoto S, Okitsu T, Iwanaga Y. Follow-up study of the first successful living donor islet transplantation. Transplantation 2006, 82:1629.
46. Gruessner RW, Kandaswamy R, Denny R. Laparoscopic simultaneous nephrectomy and distal pancreatectomy from a live donor. J Am Coll Surg 2001, 193:333.
47. Tan M, Kandaswamy R, Sutherland DE, Gruessner RW. Laparoscopic donor distal pancreatectomy for living donor pancreas and pancreas-kidney transplantation. Am J Transplant 2005, 5:1966.
48. Kumar AF, Gruessner RW, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008, 31:1639.
49. Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004, 4:2018.
50. Powner DJ. Donor care before pancreatic tissue transplantation. Prog Transplant 2005, 15:129. quiz 137
51. Salim A, Martin M, Brown C, Belzberg H, Rhee P, Demetriades D. Complications of brain death: frequency and impact on organ retrieval. Am Surg 2006, 72:377.
52. Pratschke J, Wilhelm MJ, Kusaka M. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000, 232:263.
53. Eckhoff DE, Eckstein C, Smyth CA. Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. Surgery 2004, 136:336.
54. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002, 74:1252.
55. Hesse UJ, Gores PF, Sutherland DE. Serum amylase and plasma glucose levels in pancreas cadaver donors: correlation with functional status of the pancreatic graft. Transplant Proc 1989, 21(1 Pt 3):2765.
56. Yoshida H, Hiraide A, Iwai A, Kawaguchi N, Yoshioka T, Sugimoto T. Preservation of pancreatic endocrine function by hemodynamic stabilization following brain death. Clin Transplant 1997, 11(5 Pt 1):420.
57. Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution's experience. Ann Surg 1992, 215:217.
58. Watt PC, Mullen Y, Benhamou PY. Donor factors affecting successful isolation of islets from the human pancreas. Transplant Proc 1994, 26:594.
59. Sung RS, Fiedor PS, Goodman ER. The influence of hemodynamic status in heart-beating cadaveric organ donors on subsequent pancreatic islet yield. Transplant Proc 1995, 27:3250.
60. Richter S, Yamauchi J, Minor T, Menger MD, Vollmar B. Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non-heart-beating donor rat-model. Transpl Int 2000, 13:225.
61. Braun C, Schultz M, Fang L. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin). Transplantation 2001, 72:209.
62. Kaisers U, Pappert D, Langrehr JM, Undi H, Neuhaus P, Rossaint R. Dopamine, dopexamine and dobutamine in liver transplant recipients: a comparison of their effects on hemodynamics, oxygen transport and hepatic venous oxygen saturation. Transpl Int 1996, 9:214.
63. Kaisers U, Neumann U, Kuhlen R, Sprenger M, Neuhaus P, Rossaint R. Nitroglycerin versus epoprostenol: effects on hemodynamics, oxygen delivery, and hepatic venous oxygenation after liver transplantation. Liver Transpl Surg 1996, 2:455.
64. Morimoto Y, Kamiike W, Nishida T. Improvement of rat liver graft function by insulin administration to donor. Gastroenterology 1996, 111:1071.
65. Morgan GR, Sanabria JR, Clavien PA. Correlation of donor nutritional status with sinusoidal lining cell viability and liver function in the rat. Transplantation 1991, 51:1176.
66. Cywes R, Greig PD, Sanabria JR. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg 1992, 216:235. discussion 246-7
67. Sun X, Kimura T, Kobayashi T. Viability of liver grafts from fasted donor rats: relationship to sinusoidal endothelial cell apoptosis. J Hepatobiliary Pancreat Surg 2001, 8:268.
68. Nishihara V, Sumimoto R, Fukuda Y, Southard JH, Asahara T, Dohi K. Inhibition of warm ischemic injury to rat liver, pancreas, and heart grafts by controlling the nutritional status of both donor and recipient. Surg Today 1997, 27:645.
69. Raude H, Lohde E, Luck M, Kuhn F, Abri O, Kraas E. Influence of human donor operation and isolation techniques on the viability of islets of Langerhans. Transplant Proc 1991, 23:2450.
70. Brockmann JG, Vaidya A, Reddy S, Friend PJ. Retrieval of abdominal organs for transplantation. Br J Surg 2006, 93:133.
71. Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AM. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002, 73:1106.
72. Obermaier R, Drognitz O, Benz S, Hopt UT, Pisarski P. Pancreatic ischemia/reperfusion injury: impact of different preservation temperatures. Pancreas 2008, 37:328.
73. Nagata H, Matsumoto S, Okitsu T. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation 2006, 82:327.
74. Benhamou PY, Watt PC, Mullen Y. Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 1994, 57:1804.
75. Lakey JR, Rajotte RV, Warnock GL, Kneteman NM. Human pancreas preservation prior to islet isolation. Cold ischemic tolerance. Transplantation 1995, 59:689.
76. Ketchum R, Nicolae M, Jahr H, Friedman AL, Naji A, Barker CF. Analysis of donor age and cold ischaemia as factors in cadaveric human islet isolation. Transplant Proc 1994, 26:596.
77. Zeng Y, Torre MA, Karrison T, Thistlethwaite JR. The correlation between donor characteristics and the success of human islet isolation. Transplantation 1994, 57:954.
78. Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DE. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000, 231:269.
79. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993, 265(1 Pt 1):G165.
80. Humar A, Kandaswamy R, Drangstveit MB, Parr E, Gruessner AG, Sutherland DE. Prolonged preservation increases surgical complications after pancreas transplants. Surgery 2000, 127:545.
81. Hotter G, Pi F, Sanz C. Endothelin mediated nitric oxide effects in ischemia - reperfusion associated with pancreas transplantation. Dig Dis Sci 1998, 43:2627.
82. Preissler G, Massberg S, Enders G, Waldner H, Messmer K. Effect of hypothermic preservation on ICAM-1 mRNA induction, leukocyte-endothelium interaction and microvascular perfusion after pancreas transplantation in the rat. Langenbecks Arch Chir Suppl Kongressbd 1998, 115(Suppl I):161.
83. Toyama H, Takada M, Tanaka T, Suzuki Y, Kuroda Y. Characterization of islet-infiltrating immunocytes after pancreas preservation by two-layer (UW/perfluorochemical) cold storage method. Transplant Proc 2003, 35:1503.
84. Vajkoczy P, Olofsson AM, Lehr HA. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 1995, 146:1397.
85. Vajkoczy P, Menger MD, Simpson E, Messmer K. Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation 1995, 60:123.
86. Merchant FA, Diller KR, Aggarwal SJ, Bovik AC. Angiogenesis in cultured and cryopreserved pancreatic islet grafts. Transplantation 1997, 63:1652.
87. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996, 45:1161.
88. Hughes SJ, Davies SE, Powis SH, Press M. Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Transplantation 2003, 75:1954.
89. Carlsson PO, Liss P, Andersson A, Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998, 47:1027.
90. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001, 50:489.
91. Carlsson PO, Palm F. Oxygen tension in isolated transplanted rat islets and in islets of rat whole-pancreas transplants. Transpl Int 2002, 15:581.
92. Carlsson PO, Palm F, Andersson A, Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000, 69:761.
93. Lakey JR, Warnock GL, Rajotte RV. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996, 61:1047.
94. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992, 53:957.
95. D'Alessandro AM, Stratta RJ, Sollinger HW, Kalayoglu M, Pirsch JD, Belzer FO. Use of UW solution in pancreas transplantation. Diabetes 1989, 38(Suppl 1):7.
96. Belzer FO, Ploeg RJ, Knechtle SJ. Clinical pancreas preservation and transplantation. Transplant Proc 1994, 26:550.
97. Calne RY, Pegg DE, Pryse-Davies J, Brown FL. Renal preservation by ice-cooling: an experimental study relating to kidney transplantation from cadavers. Br Med J 1963, 5358:651.
98. Woeste G, Wullstein C, Meyer S. Octreotide attenuates impaired microcirculation in postischemic pancreatitis when administered before induction of ischemia. Transplantation 2008, 86:961.
99. Iwanaga Y, Sutherland DE, Harmon JV, Papas KK. Pancreas preservation for pancreas and islet transplantation. Curr Opin Organ Transplant 2008, 13:445.
100. Dahout-Gonzalez C, Nury H, Trezeguet V, Lauquin GJ, Pebay-Peyroula E, Brandolin G. Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier. Physiology (Bethesda) 2006, 21:242.
101. Southard JH, Senzig KA, Hoffman RM, Belzer FO. Energy metabolism in kidneys stored by simple hypothermia. Transplant Proc 1977, 9:1535.
102. Yokota R, Fujiwara H, Miyamae M. Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts. Am J Physiol 1995, 268(3 Pt 2):H1149.
103. Southard JH, van Gulik TM, Ametani MS. Important components of the UW solution. Transplantation 1990, 49:251.
104. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995, 46:235.
105. Vajdova K, Smrekova R, Mislanova C, Kukan M, Lutterova M. Cold-preservation-induced sensitivity of rat hepatocyte function to rewarming injury and its prevention by short-term reperfusion. Hepatology 2000, 32:289.
106. Tanioka Y, Kuroda Y, Kim Y. The effect of ouabain (inhibitor of an ATP-dependent Na+/K+ pump) on the pancreas graft during preservation by the two-layer method. Transplantation 1996, 62:1730.
107. Fujino Y, Kuroda Y, Morita A, Tanioka Y, Ku Y, Saitoh Y. The effect of fasting and exogenous adenosine on ATP tissue concentration and viability of canine pancreas grafts during preservation by the two-layer method. Transplantation 1993, 56:1083.
108. Yuan CH, Li GC, Zhang H, Cheng Y, Zhao N, Liu YF. Evaluation of the viability and energy metabolism of canine pancreas graft subjected to significant warm ischemia damage during preservation by UW solution cold storage method. World J Gastroenterol 2004, 10:1785.
109. Wahlberg JA, Southard JH, Belzer FO. Development of a cold storage solution for pancreas preservation. Cryobiology 1986, 23:477.
110. Fukuse T, Hirata T, Nakamura T. Role of saccharides on lung preservation. Transplantation 1999, 68:110.
111. Collins GM, Green RD, Halasz NA. Importance of anion content and osmolarity in flush solutions for 48 to 72 hr hypothermic kidney storage. Cryobiology 1979, 16:217.
112. Jamieson NV, Sundberg R, Lindell S. Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation 1988, 46:517.
113. McAnulty JF, Southard JH, Belzer FO. Comparison of the effects of adenine-ribose with adenosine for maintenance of ATP concentrations in 5-day hypothermically perfused dog kidneys. Cryobiology 1988, 25:409.
114. Delmas-Beauvieux MC, Gallis JL, Rousse N, Clerc M, Canioni P. Phosphorus-31 nuclear magnetic resonance of isolated rat liver during hypothermic ischemia and subsequent normothermic perfusion. J Hepatol 1992, 15:192.
115. Delmas-Beauvieux MC, Gallis JL, Clerc M, Canioni P. 31P NMR studies of rat liver cold preservation with histidine-buffered lactobionate solution. Cryobiology 1993, 30:551.
116. Hiraoka K, Kuroda Y, Tanioka Y. Adenosine is a key component in preservation of ischemically damaged canine pancreas by the two-layer cold storage method. Transplant Proc 1994, 26:953.
117. Li JM, Fenton RA, Cutler BS, Dobson JG. Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol 1995, 1(2 Pt 1):C519.
118. Pi F, Badosa F, Sola A. Effects of adenosine on ischaemia-reperfusion injury associated with rat pancreas transplantation. Br J Surg 2001, 88:1366.
119. Vaida AM, Tang DG, Allen C, Wise RM, Higgins RS, Cohen NM. Novel protection strategy for pulmonary transplantation. J Surg Res 2003, 109:8.
120. Ritzel RA, Hansen JB, Veldhuis JD, Butler PC. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. J Clin Endocrinol Metab 2004, 89:795.
121. Baumgartner D, Sutherland DE, Heil JE, Zweber B, Awad EA, Najarian JS. Cold storage of segmental canine pancreatic grafts for 24 hours. J Surg Res 1980, 29:248.
122. Dreikorn K, Horsch R, Rohl L. 48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution. Eur Urol 1980, 6:221.
123. van Schilfgaarde R. Pancreas transplantation 1983: where do we stand? Transplant Proc 1984, 16:1287.
124. Florack G, Sutherland DE, Heil J, Zweber B, Najarian JS. Long-term preservation of segmental pancreas autografts. Surgery 1982, 92:260.
125. Toledo-Pereyra LH, Bock G, Schneider A, MacKenzie G. Pancreas preservation with TP-IV: a hyperosmolar colloid solution. Cryobiology 1985, 22:40.
126. Sutherland DE, Moudry KC, Elick BA, Goetz FC, Najarian JS, PI Terasaki. Pancreas transplant protocols at the University of Minnesota: recipient and donor selection, operative and postoperative management, and outcome. Clinical Transplants 1987 1987, 109-126. In, Los Angeles, UCLA Tissue Typing Laboratory, pp
127. Barr D, Munn SR, Carpenter HA, Perkins JD. A prospective comparison of two preservation solutions in human pancreaticoduodenal transplantation. Transplant Proc 1990, 22:529.
128. Wahlberg JA, Love R, Landegaard L, Southard JH, Belzer FO. Successful 72 hours' preservation of the canine pancreas. Transplant Proc 1987, 19(1 Pt 2):1337.
129. Pegg DE, Klempnauer J, Diaper MP, Taylor MJ. Assessment of hypothermic preservation of the pancreas in the rat by a normothermic perfusion assay. J Surg Res 1982, 33:194.
130. Viste A, Schlumpf R, Munn S, Heil JE, Condie R, Sutherland DE. 96-hour cold storage preservation of the canine pancreas. Transplant Proc 1990, 22:537.
131. Sollinger HW, Vernon WB, D'Alessandro AM, Kalayoglu M, Stratta RJ, Belzer FO. Combined liver and pancreas procurement with Belzer-UW solution. Surgery 1989, 106:685. discussion 690-1
132. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human liver grafts with UW solution. JAMA 1989, 261:711.
133. Hartgrink HH, van Bockel JH, Hansen B. Effect of blood group and HLA matching on pancreas graft survival with the use of UW solution. Transpl Int 1995, 8:366.
134. Ploeg RJ. Preliminary results of the European Multicenter Study on UW solution in liver transplantation. The Study Group. Transplant Proc 1990, 22:2185.
135. Ploeg RJ, Boudjema K, Marsh D. The importance of a colloid in canine pancreas preservation. Transplantation 1992, 53:735.
136. Urushihara T, Sumimoto R, Sumimoto K. A comparison of some simplified lactobionate preservation solutions with standard UW solution and Eurocollins solution for pancreas preservation. Transplantation 1992, 53:750.
137. Moen J, Claesson K, Pienaar H. Preservation of dog liver, kidney, and pancreas using the Belzer-UW solution with a high-sodium and low-potassium content. Transplantation 1989, 47:940.
138. Ploeg RJ, Goossens D, Sollinger HW, Southard JH, Belzer FO. The Belzer-UW solution for effective long-term preservation in canine pancreas transplantation. Transplant Proc 1989, 21(1 Pt 2):1378.
139. Tojimbara T, Wicomb WN, Garcia-Kennedy R. Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function. Liver Transpl Surg 1997, 3:39.
140. Tullius SG, Filatenkow A, Horch D. Accumulation of crystal deposits in abdominal organs following perfusion with defrosted University of Wisconsin solutions. Am J Transplant 2002, 2:627.
141. Roberts RF, Nishanian GP, Carey JN, Sakamaki Y, Starnes VA, Barr ML. A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin solutions in lung reperfusion injury. Transplantation 1999, 67:152.
142. Carrier M, Trudel S, Pelletier LC. Effect of Celsior and University of Wisconsin solutions on myocardial metabolism and function after warm ischemia. J Cardiovasc Surg (Torino) 1999, 40:811.
143. Vega JD, Ochsner JL, Jeevanandam V. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 2001, 71:1442.
144. Hesse UJ, Troisi R, Jacobs B. Cold preservation of the porcine pancreas with histidine-tryptophan-ketoglutarate solution. Transplantation 1998, 66:1137.
145. Leonhardt U, Tytko A, Exner B. The effect of different solutions for organ preservation on immediate postischemic pancreatic function in vitro. Transplantation 1993, 55:11.
146. Troisi R, Meester D, Van Den Broecke C. Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine-tryptophan-ketoglutarate (custodiol) or University of Wisconsin solution. Transplantation 2003, 75:1793.
147. Schneeberger S, Biebl M, Steurer W. A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation. Transpl Int 2009, 22:217.
148. Boggi U, Vistoli F, Del Chiaro M. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study. Transplantation 2004, 77:1186.
149. Agarwal A, Powelson JA, Goggins WC, Milgrom ML, Fridell JA. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: an update of the indiana university experience. Transplant Proc 2008, 40:498.
150. Alonso D, Dunn TB, Rigley T. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008, 8:1942.
151. Stewart ZA, Cameron AM, Singer AL, Dagher NN, Montgomery RA, Segev DL. Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009, 9:217.
152. Robertson GS, Chadwick D, Thirdborough S. Human islet isolation - a prospective randomized comparison of pancreatic vascular perfusion with hyperosmolar citrate or University of Wisconsin solution. Transplantation 1993, 56:550.
153. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 2003, 75:1965.
154. Ohzato H, Gotoh M, Monden M. Intraductal injection of collagenase solution at the time of harvesting: a possible solution for preservation and collagenase digestion. Transplant Proc 1990, 22:782.
155. White SA, Contractor HH, Hughes DP. Influence of different collagenase solvents and timing of their delivery on porcine islet isolation. Br J Surg 1996, 83:1350.
156. Cross SE, Hughes SJ, Partridge CJ, Clark A, Gray DW, Johnson PR. Collagenase penetrates human pancreatic islets following standard intraductal administration. Transplantation 2008, 86:907.
157. Traverso LW, Abu-Zamzam AM. Activation of pancreatic proteolytic enzymes by commercial collagenases. Transplantation 1978, 25:226.
158. London NJ, Lake SP, Wilson J. A simple method for the release of islets by controlled collagenase digestion of the human pancreas. Transplantation 1990, 49:1109.
159. Casanova D, Perojo I, Ramos C. Human islet isolation in fresh pancreas or after preservation in UW solution. Transplant Proc 2002, 34:191.
160. Robertson GS, Chadwick D, Contractor H. Storage of human pancreatic digest in University of Wisconsin solution significantly improves subsequent islet purification. Br J Surg 1992, 79:899.
161. Robertson GS, Chadwick DR, Davies J. The effectiveness of components of University of Wisconsin solution in improving human pancreatic islet purification. Transplantation 1994, 57:346.
162. Chadwick DR, Robertson GS, Rose S. Storage of porcine pancreatic digest prior to islet purification. The benefits of UW solution and the roles of its individual components. Transplantation 1993, 56:288.
163. Chadwick DR, Robertson GS, Contractor HH. Storage of pancreatic digest before islet purification. The influence of colloids and the sodium to potassium ratio in University of Wisconsin-based preservation solutions. Transplantation 1994, 58:99.
164. Kneteman NM, DeGroot TJ, Warnock GL, Rajotte RV. The evaluation of solutions for pancreas preservation prior to islet isolation. Horm Metab Res Suppl 1990, 25:4.
165. Kneteman NM, Warnock GL, Evans MG, Dawidson I, Rajotte RV. Islet isolation from human pancreas stored in UW solution for 6 to 26 hours. Transplant Proc 1990, 22:763.
166. Kneteman NM, Wagner T. Critical components of storage fluid for pancreas preservation before islet isolation. Transplant Proc 1992, 24:2824.
167. Hering BJ, Kandaswamy R, Ansite JD. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005, 293:830.
168. Kin T, Senior P, O'Gorman D, Richer B, Salam A, Shapiro AM. Risk factors for islet loss during culture prior to transplantation. Transpl Int 2008, 21:1029.
169. Belzer FO, Kalayoglu M, D'Alessandro AM. Organ preservation: experience with University of Wisconsin solution and plans for the future. Clin Transplant 1990, 4:73.
170. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988, 46:457.
171. Fujino Y, Kuroda Y, Suzuki Y. Preservation of canine pancreas for 96 hours by a modified two-layer (UW solution/perfluorochemical) cold storage method. Transplantation 1991, 51:1133.
172. Maillard E, Sanchez-Dominguez M, Kleiss C. Perfluorocarbons: new tool for islets preservation in vitro. Transplant Proc 2008, 40:372.
173. Kuroda Y, Morita A, Fujino Y, Tanioka Y, Ku Y, Saitoh Y. Restoration of pancreas graft function preserved by a two-layer (University of Wisconsin solution/perfluorochemical) cold storage method after significant warm ischemia. Transplantation 1993, 55:227.
174. Kuroda Y, Tanioka Y, Morita A. Protective effect of preservation of canine pancreas by the two-layer (University of Wisconsin solution/perfluorochemical) method against rewarming ischemic injury during implantation. Transplantation 1994, 57:658.
175. Kuroda Y, Tanioka Y, Matsumoto S. Difference in energy metabolism between fresh and warm ischemic canine pancreases during preservation by the two-layer method. Transpl Int 1994, 7(Suppl 1):S441.
176. Kuroda Y, Hiraoka K, Tanioka Y. Role of adenosine in preservation by the two-layer method of ischemically damaged canine pancreas. Transplantation 1994, 57:1017.
177. Matsumoto S, Kuroda Y, Fujita H. Extending the margin of safety of preservation period for resuscitation of ischemically damaged pancreas during preservation using the two-layer (University of Wisconsin solution/perfluorochemical) method at 20 degrees C with thromboxane A2 synthesis inhibitor OKY046. Transplantation 1996, 62:879.
178. Iwanaga Y, Suzuki Y, Okada Y. Ultrastructural analyses of pancreatic grafts preserved by the two-layer cold-storage method and by simple cold storage in University of Wisconsin solution. Transpl Int 2002, 15:425.
179. Papas KK, Hering BJ, Guenther L, Rappel MJ, Colton CK, Avgoustiniatos ES. Pancreas oxygenation is limited during preservation with the two-layer method. Transplant Proc 2005, 37:3501.
180. Scott WE, Matsumoto S, Tanaka T. Real-time noninvasive assessment of pancreatic ATP levels during cold preservation. Transplant Proc 2008, 40:403.
181. Matsumoto S, Kandaswamy R, Sutherland DE. Clinical application of the two-layer (University of Wisconsin solution/perfluorochemical plus O2) method of pancreas preservation before transplantation. Transplantation 2000, 70:771.
182. Tanioka Y, Sutherland DE, Kuroda Y. Excellence of the two-layer method (University of Wisconsin solution/perfluorochemical) in pancreas preservation before islet isolation. Surgery 1997, 122:435. discussion 441-2
183. Brandhorst D, Iken M, Tanioka Y, Brendel MD, Bretzel RG, Brandhorst H. Influence of collagenase loading on long-term preservation of pig pancreas by the two-layer method for subsequent islet isolation. Transplantation 2005, 79:38.
184. Matsumoto S, Lawrence O, Rigley TH, Lakey JR, Stevens RB, Strong DM. University of wisconsin solution with trypsin inhibitor pefabloc improves survival of viable human and primate impure islets during storage. Cell Tissue Bank 2001, 2:15.
185. Matsumoto S, Iwanaga Y, Okitsu T. Analysis of large-scale nonhuman primate islet isolations. Transplant Proc 2005, 37:1317.
186. Hiraoka K, Trexler A, Eckman E. Successful pancreas preservation before islet isolation by the simplified two-layer cold storage method. Transplant Proc 2001, 33:952.
187. Tsujimura T, Kuroda Y, Kin T. Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation 2002, 74:1687.
188. Matsumoto S, Qualley SA, Goel S. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002, 74:1414.
189. Kakinoki K, Fujino Y, Suzuki Y. Superiority of the two-layer method before islet isolation confirmed by in vivo viability assessment. Transplantation 2005, 79:1516.
190. Hering BJ, Kandaswamy R, Harmon JV. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004, 4:390.
191. Tsujimura T, Kuroda Y, Avila JG. Resuscitation of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Transplant Proc 2003, 35:2461.
192. Tsujimura T, Kuroda Y, Churchill TA. Short-term storage of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Cell Transplant 2004, 13:67.
193. Ricordi C, Fraker C, Szust J. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003, 75:1524.
194. Tsujimura T, Kuroda Y, Avila JG. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation 2004, 78:96.
195. Witkowski P, Liu Z, Guo Q. Two-layer method in short-term pancreas preservation for successful islet isolation. Transplant Proc 2005, 37:3398.
196. Matsumoto S, Zhang G, Qualley S. The effect of two-layer (University of Wisconsin solution/perfluorochemical) preservation method on clinical grade pancreata prior to islet isolation and transplantation. Transplant Proc 2004, 36:1037.
197. Noguchi H, Nakai Y, Matsumoto S. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant 2005, 5:1848.
198. Zhang G, Matsumoto S, Newman H, Strong DM, Robertson RP, Reems JA. Improve islet yields and quality when clinical grade pancreata are preserved by the two-layer method. Cell Tissue Bank 2006, 7:195.
199. Miyamoto M, Morimoto Y, Balamurugan AN. Improvement of modified two-layer preservation method (PFC/Kyoto solution) in islet isolation from breeder pigs. Transplant Proc 2000, 32:1660.
200. Brandhorst D, Iken M, Bretzel RG, Brandhorst H. Pancreas storage in oxygenated perfluorodecalin does not restore post-transplant function of isolated pig islets pre-damaged by warm ischemia. Xenotransplantation 2006, 13:465.
201. Brandhorst D, Iken M, Brendel MD, Bretzel RG, Brandhorst H. Successful pancreas preservation by a perfluorocarbon-based one-layer method for subsequent pig islet isolation. Transplantation 2005, 79:433.
202. Kin T, Mirbolooki M, Salehi P. Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation 2006, 82:1286.
203. Caballero-Corbalan J, Eich T, Lundgren T. No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation. Transplantation 2007, 84:864.
204. Dutkowski P, Furrer K, Tian Y, Graf R, Clavien PA. Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg 2006, 244:968. discussion 976-7
205. Doorschodt BM, Bessems M, van Vliet AK, van Gulik TM. The first disposable perfusion preservation system for kidney and liver grafts. Ann Transplant 2004, 9:40.
206. Peerlinck ID, Barlas A, Karameris A, Papalois VE. The effect of machine perfusion on the arteries of porcine kidneys. Exp Clin Transplant 2005, 3:375.
207. Ricordi C, Finke EH, Lacy PE. A method for the mass isolation of islets from the adult pig pancreas. Diabetes 1986, 35:649.
208. Westbroek DL, De Gruyl J, Dijkhuis CM. Twenty-four-hour hypothermic preservation perfusion and storage of the duct-ligated canine pancreas with transplantation. Transplant Proc 1974, 6:319.
209. de Gruyl J, Westbroek DL, Macdicken I, Ridderhof E, Verschoor L, van Strik R. Cryoprecipitated plasma perfusion preservation and cold storage preservation of duct-ligated pancreatic allografts. Br J Surg 1977, 64:490.
210. Tersigni R, Toledo-Pereyra LH, Pinkham J, Najarian JS. Pancreaticoduodenal preservation by hypothermic pulsatile perfusion for twenty-four hours. Ann Surg 1975, 182:743.
211. Tersigni R, Toledo-Pereyra LH, Najarian JS. Effects of methylprednisolone, glucagon, and allopurinol in the protection of pancreaticoduodenal allografts perfused for twenty-four hours. Surgery 1975, 78:599.
212. Brynger H. Twenty-four-hour preservation of the duct-ligated canine pancreatic allograft. Eur Surg Res 1975, 7:341.
213. Florack G, Sutherland DE, Heil J, Squifflet JP, Najarian JS. Preservation of canine segmental pancreatic autografts: cold storage versus pulsatile machine perfusion. J Surg Res 1983, 34:493.
214. Taylor MJ, Baicu S, Leman B, Greene E, Vazquez A, Brassil J. Twenty-four hour hypothermic machine perfusion preservation of porcine pancreas facilitates processing for islet isolation. Transplant Proc 2008, 40:480.
215. Leeser DB, Bingaman AW, Poliakova L. Pulsatile pump perfusion of pancreata before human islet cell isolation. Transplant Proc 2004, 36:1050.
216. Ridgway DM, Swift SM, Nicholson ML, White SA. Preservation of the porcine pancreas: an assessment using ADP:ATP ratio. Am J Transplant 2008, 8(Suppl 2):509.
217. Minor T, Sitzia M, Dombrowski F. Kidney transplantation from non-heart-beating donors after oxygenated low-flow machine perfusion preservation with histidine-tryptophan-ketoglutarate solution. Transpl Int 2005, 17:707.
218. Lindell SL, Compagnon P, Mangino MJ, Southard JH. UW solution for hypothermic machine perfusion of warm ischemic kidneys. Transplantation 2005, 79:1358.
219. Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, Nicholson ML. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg 2008, 95:111.
220. Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, Nicholson ML. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg 2008, 95:111.
221. Baicu SC, Taylor MJ, Brockbank KG. The role of preservation solution on acid-base regulation during machine perfusion of kidneys. Clin Transplant 2006, 20:113.
222. Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM. Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transpl 2005, 11:1379.
223. Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM. Improved rat liver preservation by hypothermic continuous machine perfusion using polysol, a new, enriched preservation solution. Liver Transpl 2005, 11:539.
224. Guarrera JV, Polyak M, O'Mar Arrington B, Kapur S, Stubenbord WT, Kinkhabwala M. Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation. Transplantation 2004, 77:1264.
225. Gage FA, Vodovotz Y. Normalization of nitric oxide flux improves physiological parameters of porcine kidneys maintained on pulsatile perfusion. Nitric Oxide 2003, 9:141.
226. Polyak MM, Arrington BO, Kapur S, Stubenbord WT, Kinkhabwala M. Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function. Transplantation 2000, 69:184.